InsidersTradesSigma
Discover the full record of transactions filed by Canute Scott A, Director. Officer active across 1 companies, notably Flexion Therapeutics Inc. Aggregated, 4 reports have been recorded. The latest transaction was disclosed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Scott A. Canute is a Board Member at Flexion Therapeutics Inc. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for pain. With a strong background in the pharmaceutical industry, Scott A. Canute helps Flexion navigate the competitive landscape and achieve its research and development goals.